Jenny N Poynter1, Michaela Richardson2, Cindy K Blair3, Michelle A Roesler4, Betsy A Hirsch5, Phuong Nguyen6, Adina Cioc7, Erica Warlick8, James R Cerhan9, Julie A Ross10. 1. Division of Epidemiology and Clinical Research, Department of Pediatrics, University of Minnesota, Minneapolis, MN 55455, United States; Masonic Cancer Center, University of Minnesota, Minneapolis, MN 55455, United States. Electronic address: poynt006@umn.edu. 2. Division of Epidemiology and Clinical Research, Department of Pediatrics, University of Minnesota, Minneapolis, MN 55455, United States. 3. Division of Epidemiology, School of Public Health, University of Minnesota, Minneapolis, MN 55455, United States. 4. Masonic Cancer Center, University of Minnesota, Minneapolis, MN 55455, United States. 5. Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, MN 55455, United States. 6. Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN 55905, United States. 7. VA Medical Center, Minneapolis, MN 55417, United States. 8. Blood and Marrow Transplant Program, Division of Hematology, Oncology, and Transplantation, University of Minnesota, Minneapolis, MN 55455, United States. 9. Division of Epidemiology, Department of Health Sciences Research, Mayo Clinic, Rochester, MN 55905, United States. 10. Division of Epidemiology and Clinical Research, Department of Pediatrics, University of Minnesota, Minneapolis, MN 55455, United States; Masonic Cancer Center, University of Minnesota, Minneapolis, MN 55455, United States.
Abstract
BACKGROUND: Overweight and obesity are known risk factors for a number of cancers, with recent evidence suggesting that risk of hematologic cancer is also increased in obese individuals. We evaluated associations between body mass index (BMI) at differing time points during the life course in population-based case control studies of acute myeloid leukemia (AML) and myelodysplatic syndromes (MDS). METHODS: Cases were identified by the Minnesota Cancer Surveillance System. Controls were identified through the Minnesota State driver's license/identification card list. BMI was calculated using self-reported height and weight at ages 18, 35, and 50 years and two years prior to interview, and categorized as normal (18.5-25 kg/m(2)), overweight (25-29.9 kg/m(2)), obese class I (30-34.9 kg/m(2)), and obese class II/III (35+ kg/m(2)). All analyses were stratified by sex. Unconditional logistic regression was used to calculate odds ratios and 95% confidence intervals. RESULTS: We included 420 AML cases, 265 MDS cases and 1388 controls. Obesity two years prior to diagnosis was associated with AML in both males and females (OR=2.22, 95% CI 1.28, 3.85 and OR=1.85, 95% CI 1.08, 3.15 for BMI≥35 vs. BMI 18.5-24.9, respectively). In contrast, associations between obesity and MDS were observed only in females. Weight change in adulthood was not consistently associated with either outcome. CONCLUSION: Our results extend the emerging literature suggesting that obesity is a risk factor for hematologic malignancy and provide evidence that that the association remains regardless of timing of obesity. Obesity in adulthood is a modifiable risk factor for both MDS and AML.
BACKGROUND: Overweight and obesity are known risk factors for a number of cancers, with recent evidence suggesting that risk of hematologic cancer is also increased in obese individuals. We evaluated associations between body mass index (BMI) at differing time points during the life course in population-based case control studies of acute myeloid leukemia (AML) and myelodysplatic syndromes (MDS). METHODS: Cases were identified by the Minnesota Cancer Surveillance System. Controls were identified through the Minnesota State driver's license/identification card list. BMI was calculated using self-reported height and weight at ages 18, 35, and 50 years and two years prior to interview, and categorized as normal (18.5-25 kg/m(2)), overweight (25-29.9 kg/m(2)), obese class I (30-34.9 kg/m(2)), and obese class II/III (35+ kg/m(2)). All analyses were stratified by sex. Unconditional logistic regression was used to calculate odds ratios and 95% confidence intervals. RESULTS: We included 420 AML cases, 265 MDS cases and 1388 controls. Obesity two years prior to diagnosis was associated with AML in both males and females (OR=2.22, 95% CI 1.28, 3.85 and OR=1.85, 95% CI 1.08, 3.15 for BMI≥35 vs. BMI 18.5-24.9, respectively). In contrast, associations between obesity and MDS were observed only in females. Weight change in adulthood was not consistently associated with either outcome. CONCLUSION: Our results extend the emerging literature suggesting that obesity is a risk factor for hematologic malignancy and provide evidence that that the association remains regardless of timing of obesity. Obesity in adulthood is a modifiable risk factor for both MDS and AML.
Authors: Julie A Ross; Emily Parker; Cindy K Blair; James R Cerhan; Aaron R Folsom Journal: Cancer Epidemiol Biomarkers Prev Date: 2004-11 Impact factor: 4.254
Authors: Khaled Kasim; Patrick Levallois; Belkacem Abdous; Pierre Auger; Kenneth C Johnson Journal: Cancer Causes Control Date: 2005-06 Impact factor: 2.506
Authors: Claudine Samanic; Gloria Gridley; Wong-Ho Chow; Jay Lubin; Robert N Hoover; Joseph F Fraumeni Journal: Cancer Causes Control Date: 2004-02 Impact factor: 2.506
Authors: M Konopleva; A Mikhail; Z Estrov; S Zhao; D Harris; G Sanchez-Williams; S M Kornblau; J Dong; K O Kliche; S Jiang; H R Snodgrass; E H Estey; M Andreeff Journal: Blood Date: 1999-03-01 Impact factor: 22.113
Authors: T Gainsford; T A Willson; D Metcalf; E Handman; C McFarlane; A Ng; N A Nicola; W S Alexander; D J Hilton Journal: Proc Natl Acad Sci U S A Date: 1996-12-10 Impact factor: 11.205
Authors: Vladimir Lj Lazarevic; Anders Bredberg; Fryderyk Lorenz; Emma Öhlander; Petar Antunovic; Jörg Cammenga; Lovisa Wennström; Lars Möllgård; Stefan Deneberg; Åsa Derolf; Martin Höglund; Gunnar Juliusson Journal: Haematologica Date: 2018-06-28 Impact factor: 9.941
Authors: Elizabeth A Duffy; Phuong L Nguyen; Adina Cioc; Erica Warlick; Michelle A Roesler; Jenny N Poynter Journal: Cancer Causes Control Date: 2020-04-13 Impact factor: 2.506